Publicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (19)

2018

  1. Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

    Expert Opinion on Drug Safety, Vol. 17, Núm. 6, pp. 573-579

2015

  1. Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. Stem cells in cancer: Should we believe or not?

    Springer Netherlands, pp. 1-299

  2. The universal stem cell source: Does it exist?

    Stem Cells in Cancer: Should We Believe or Not? (Springer Netherlands), pp. 1-22

2012

  1. A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab

    Clinical Genitourinary Cancer, Vol. 10, Núm. 3, pp. 199-201

  2. Cytokine and endocrine signaling in prostate cancer

    Medical Oncology, Vol. 29, Núm. 3, pp. 1956-1963

  3. Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?

    Cancer metastasis reviews, Vol. 31, Núm. 1-2, pp. 47-53

  4. Sunitinib: The first to arrive at first-line metastatic renal cell carcinoma

    Advances in Therapy, Vol. 29, Núm. 3, pp. 202-217

  5. Vinflunine: A new vision that may translate into antiangiogenic and antimetastatic activity

    Anti-Cancer Drugs, Vol. 23, Núm. 1, pp. 1-11

2011

  1. Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 16, pp. 2433-2439

  2. Fructose transporter GLUT5 expression in clear renal cell carcinoma

    Oncology Reports, Vol. 25, Núm. 2, pp. 315-323

  3. New insights into molecular mechanisms of sunitinib-associated side effects

    Molecular Cancer Therapeutics, Vol. 10, Núm. 12, pp. 2215-2223

  4. Stem cell and lung cancer development: Blaming the Wnt, Hh and notch signalling pathway

    Clinical and Translational Oncology, Vol. 13, Núm. 2, pp. 77-83

  5. Sunitinib-induced asthenia: From molecular basis to clinical relief

    Cancer Biology and Therapy, Vol. 12, Núm. 9, pp. 765-771

2010

  1. Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters

    Molecular Medicine Reports, Vol. 3, Núm. 4, pp. 575-580

  2. Potential role of sugar transporters in cancer and their relationship with anticancer therapy

    International Journal of Endocrinology, Vol. 2010

  3. Renal cell carcinoma: Complete pathological response in a patient with gastric metastasis of renal cell carcinoma

    Anti-Cancer Drugs, Vol. 21, Núm. SUPPL.1

2009

  1. Prostate stem cells and cell differentiation

    Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 211-241

  2. The role of COX-2 in prostate carcinoma: Therapeutical implications

    Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 363-388